Home›Stock Screener›Prism Medico & Pharmacy

Prism Medico & Pharmacy Share Price Today | Stock Price & Prism Medico & Pharmacy Share Screener

PRISMMEDI Finance
Live Share Price BSE
₹34.95
▲ 0.45 (1.30%)
2026-11-19 00:00:00

As of November 19, 2026, the live Prism Medico & Pharmacy share price (BSE: PRISMMEDI) is ₹34.95, up 1.30% from the previous close, with shares trading between ₹34.10 and ₹35.00 in today's trading session, and a 52-week range of ₹16.03–₹36.18. Track PRISMMEDI market value to gauge the company's total market size. Use the Prism Medico & Pharmacy stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Prism Medico & Pharmacy opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Prism Medico & Pharmacy Market Cap ₹46.46 Cr.
PRISMMEDI P/E Ratio (TTM) -575.00
Prism Medico & Pharmacy P/B Ratio 1.41
EPS (TTM) ₹0.07
Dividend Yield -
Debt to Equity 0.17
PRISMMEDI 52 Week High ₹36.18
Prism Medico & Pharmacy 52 Week Low ₹16.03
Operating Margin -
Profit Margin -
PRISMMEDI Revenue (TTM) ₹10.00
EBITDA -
Net Income -
Total Assets ₹21.00
Total Equity ₹13.00

Prism Medico & Pharmacy Share Price Chart

Track the current stock price of Prism Medico & Pharmacy with an interactive chart. Analyse PRISMMEDI share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Prism Medico & Pharmacy stock quote in one place.

The quote of ₹34.95 sits between the 52-week low of ₹16.03 and the 52-week high of ₹36.18, and the latest session moved 1.30% from the previous close.

Prism Medico & Pharmacy Company Profile - Fundamental Screener

Screen Prism Medico & Pharmacy company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for PRISMMEDI shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Financial Services sector and the Finance industry, and it trades under ISIN INE730E01016.

Company Details

Classification

Sector Financial Services
Industry Finance
Sub-Sector Finance
Segment E

Identifiers and Leadership

ISIN INE730E01016

Prism Medico & Pharmacy Balance Sheet Screener

Screen PRISMMEDI balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2019, total assets were ₹21, up from ₹16 in 2018.

Latest statistics put total assets at ₹21 and shareholder funds at ₹13, with a leverage ratio of 0.17.

Item 2019 2018 2017

Assets

Total Assets 21 16 17
Current Assets 0 0 0
Fixed Assets 9 9 10

Liabilities

Total Liabilities 0 0 0
Current Liabilities 0 0 3
Non-Current Liabilities 0 0 0

Shareholders' Equity

Total Equity 13 13 13
Share Capital 6 6 6
Reserves & Surplus 7 7 7

Prism Medico & Pharmacy Income Statement Screener - Profit & Revenue Analysis

Screen Prism Medico & Pharmacy income statement and profit fundamentals. Analyze PRISMMEDI quarterly results. Prism Medico & Pharmacy reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2019-Dec, revenue was ₹10 and net profit was ₹0, equal to earnings per unit of ₹-0.07.

In that period expenses were ₹10, interest cost ₹0 and tax ₹0. The next period listed, 2019-Sept, shows revenue of ₹7 and net profit of ₹0.

Item 2019-Dec 2019-Sept 2019-Jun 2019-Mar 2018-Dec 2018-Sept 2018-Jun 2018-Mar 2017-Dec 2017-Sept 2017-Jun 2017-Mar 2016-Jun 2016-Mar

Revenue and Expenses

Revenue 10 7 9 17 17 15 6 0 5 6 12 3 0 0
Expenses 10 6 9 17 17 15 5 1 5 6 11 2 0 0

Operating Costs and Margins

EBITDA 0 0 0 -1 0 0 1 0 0 0 1 1 0 0
Operating Profit % 0.00% 3.00% 2.00% -5.00% 1.00% 2.00% 7.00% -50.00% 1.00% 1.00% 7.00% 26.00% 0.00% 0.00%
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0 0

Profit and Earnings

Profit Before Tax 0 0 0 -1 0 0 0 0 0 0 1 1 0 0
Tax 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Profit 0 0 0 -1 0 0 0 0 0 0 1 1 0 0
EPS -0.07 0.15 0.21 -1.21 0.24 0.46 0.62 -0.70 -0.19 -0.23 1.12 0.90 -0.53 0.00

Prism Medico & Pharmacy Cash Flow Screener - Liquidity Fundamentals

Screen PRISMMEDI cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2019-March, operating activities generated ₹0, and net cash flow was an outflow of ₹1.

Over the same period, investing activities provided ₹0 and financing activities used ₹1.

Item 2019-March 2018-March 2017-March

Cash from Operations and Investing

Operating Activities 0 4 0
Investing Activities 0 -3 0

Financing and Net Cash

Financing Activities -1 -2 0
Net Cash Flow -1 -1 0

Prism Medico & Pharmacy Shareholding Pattern Screener

See Prism Medico & Pharmacy shareholding pattern with promoter, FII, and DII holdings. Check Prism Medico & Pharmacy promoter holding and ownership changes for PRISMMEDI on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Sept, promoters held 29.98%, foreign institutions 0.00%, domestic institutions 0.00% and the public 65.88%, spread across 4,136 shareholders.

The shareholder count was 4,136 in 2026-Sept, compared with 4,177 in 2026-Jun.

Item 2026-Sept 2026-Jun 2026-Mar 2026-May 2025-Mar 2025-Jun 2025-Sept 2025-Dec

Promoter Holding

Promoter Holding 29.98% 29.98% 25.49% 30.20% 25.00% 25.00% 25.00% 25.00%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 65.88% 65.94% 66.00% 66.00% 66.07% 65.26% 65.26% 65.63%
Other Holding 4.14% 4.08% 8.51% 3.80% 8.93% 9.74% 9.74% 9.37%
Shareholder Count 4,136 4,177 4,295 4,300 4,302 4,306 4,315 4,306

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Prism Medico & Pharmacy. Prism Medico & Pharmacy dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Prism Medico & Pharmacy.

Prism Medico & Pharmacy Stock Index Membership - Nifty & Sensex

See which indices include Prism Medico & Pharmacy stock. Check PRISMMEDI index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Prism Medico & Pharmacy is not part of any tracked indices.
Only major market indices are tracked in our system.

Prism Medico & Pharmacy Market Events Screener - Corporate Actions

Get Prism Medico & Pharmacy corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Prism Medico & Pharmacy stock events that may affect PRISMMEDI share price, along with derivatives, futures and options activity and sector gainers.

14 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 5, 2026, with a record date of November 5, 2026.

It is followed by Annual General Meeting dated September 19, 2026 and Quarterly Result Announcement dated August 12, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-11-05 2026-11-05 Quarterly Result Announcement NA -2.54%
2026-09-19 2026-09-19 Annual General Meeting NA 0.51%
2026-08-12 2026-08-12 Quarterly Result Announcement NA -8.63%
2026-05-28 2026-05-28 Quarterly Result Announcement NA -4.95%
2026-03-20 2026-03-20 Extraordinary General Meeting NA 13.11%
2026-02-13 2026-02-13 Quarterly Result Announcement NA -7.32%
2025-11-14 2025-11-14 Quarterly Result Announcement NA 1.89%
2025-09-30 2025-09-30 Annual General Meeting NA 20.06%
2025-08-14 2025-08-14 Quarterly Result Announcement NA 0.65%
2025-05-28 2025-05-28 Quarterly Result Announcement NA 13.42%
2025-02-14 2025-02-14 Quarterly Result Announcement NA -3.47%
2024-11-14 2024-11-14 Quarterly Result Announcement NA 2.04%
2024-09-30 2024-09-30 Annual General Meeting NA -14.25%
2018-05-30 2018-05-30 Change Of Name NA 0.00%

Prism Medico & Pharmacy Competitors Screener - Peer Stocks Comparison

Screen PRISMMEDI competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Financial Services sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Bajaj Finance 684,264 31.40 81,990 19.09% 19,332 63.36
Bajaj Finserv 301,476 13.60 150,530 13.23% 19,670 60.23
Shriram Finance 227,316 18.00 48,193 15.13% 10,004 55.60
Cholamandalam Investment 159,286 25.60 31,539 20.59% 5,229 70.83
Jio Financial Services 148,868 89.60 3,543 70.41% 1,561 53.02
Tata Capital 144,495 23.30 31,583 11.32% 4,891 51.33
Bajaj Holdings & Investments 126,474 13.30 1,124 35.18% 9,789 56.18
Aditya Birla Capital 114,327 24.50 45,617 12.02% 3,864 63.88
Power Finance Corporation 109,184 3.20 115,533 8.38% 33,625 43.60
IRFC 108,534 14.40 27,338 0.67% 7,009 52.87

Prism Medico & Pharmacy Company Announcements - News & Reports Screener

Screen PRISMMEDI latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated November 5, 2026.

The next most recent announcements are dated October 31, 2026 and October 29, 2026.

Date Update Actions
2026-11-05 Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. -
2026-10-31 Board Meeting Intimation for Regulation 29(1) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. -
2026-10-29 Undertaking Of Functional Website. -
2026-10-13 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-10-05 Compliance-57 (5) : intimation after the end of quarter -
2026-09-30 Compliance-57 (4) : Prior intimation to the beginning of the quarter -
2026-09-30 Closure of Trading Window -
2026-09-22 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-09-19 Regulation 30(2) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 - Proceedings Of 24Th Annual General Meeting Held On 19Th September 2026. -
2026-09-19 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-08-26 Reg. 34 (1) Annual Report. -
2026-08-24 Intimation Of Record Date. -
2026-08-24 Intimation Of Book Closure. -
2026-08-24 Annual Report For The Financial Year 2025-2026. -
2026-08-24 Annual Report For The Financial Year 2025-2026. -
2026-08-24 Notice Of 24Th Annual General Meeting. -
2026-08-24 Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. -
2026-08-19 Board Meeting Intimation for Regulation 29(1) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015. -
2026-08-12 Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. -
2026-08-05 Board Meeting Intimation for Regulation 29(1) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹34.95, within a 52-week range of ₹16.03 to ₹36.18. The P/E ratio is -575.00 and the P/B ratio is 1.41, with earnings per unit of ₹0.07. Market capitalisation stands at ₹46.46 Cr. The company operates in the Financial Services sector, in the Finance industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the BSE. Key statistics were last updated on November 21, 2026. This page covers 3 balance sheet periods, 14 income statement periods, 3 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.